scholarly journals Clinicopathological features of pediatric renal biopsies in the plateau regions of China

2018 ◽  
Vol 46 (11) ◽  
pp. 4539-4546 ◽  
Author(s):  
Nini Wang ◽  
Tingting Zhu ◽  
Yuhong Tao
Keyword(s):  
Kidney Diseases ◽  
Clinicopathological Features ◽  
University Hospital ◽  
Henoch Schonlein Purpura ◽  
B Virus ◽  
Renal Biopsies ◽  
Primary Glomerular Disease ◽  
Schonlein Purpura ◽  
Henoch Schönlein Purpura ◽  
Purpura Nephritis

Objective This study aimed to analyze the clinicopathological features of pediatric renal biopsies from plateau regions of China. Methods Clinicopathological features of pediatric renal biopsies were compared between plateau and non-plateau regions in patients who were admitted to West China Second University Hospital, Sichuan University between April 2001 and March 2017. Patients were children younger than 18 years. Results The proportion of primary glomerular disease in the plateau group was lower than that in the non-plateau group (45.56% vs 62.09%, respectively). In the plateau group, IgA nephropathy (IgAN) was the major primary glomerulonephritis (GN) pathology. IgAN accounted for 36.54% and 21.63% of GN cases with nephrotic syndrome and hematuria, respectively. Henoch-Schönlein purpura nephritis was the most common secondary GN in both groups. The proportion of hepatitis B virus-associated GN was higher and that of lupus nephritis was lower in the plateau group than in the non-plateau group. Conclusions There are differences in renal pathological types between children in plateau regions and those in non-plateau regions. Among children in plateau regions, IgAN and Henoch-Schönlein purpura nephritis were the most common kidney diseases.

scholarly journals Henoch-Schonlein Purpura in Children at Department of Pediatric, Bach Mai Hospital

2020 ◽  
Vol 36 (1) ◽  
Author(s):  
Pham Van Dem
Keyword(s):  
Quality Of Life ◽  
Kidney Diseases ◽  
Total Quality ◽  
Henoch Schonlein Purpura ◽  
Chronic Kidney Diseases ◽  
Life Score ◽  
Schonlein Purpura ◽  
Henoch Schönlein Purpura ◽  
Purpura Nephritis

Objectives: To identify the percentage of parents having the correct knowledge of caring their children and evaluable quality of life in children with chronic kidney diseases. Subject and method: descriptive cross sectional study and  evaluated the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales of 115 children with chronic kidney diseases (CKD) and their parents who treated at Department of Pediatric of Bach Mai hospital. Results: the parents’ correct knowledge about CKD was persistant and relapse (90,4% and 89,4%). The sourse of information parents’s from medical staffs was 48,2% and 23% from social networking. Over 50% of parents thought that knowledge getting from medical staffs was necessary. Beside that 33% of parents thought that information gettinh from social networking was harmful. Total quality of life score of children with CKD was 21,9 ± 14,9  point. Physical and learning field were more effective. However, total quality of life score of children with CKD whose parents got consulting of medical staffs was lower than wothout medical staffs’s consulting. The difference between total quality of life score of children with CKD and job of parents was not is not statistically significant. Conclusion: the supply more information will help parents understand their role in co-operation with medical staffs to help the children integrate into the normal society and enhance their quality of life. Keywords Knowledge,chronic kidney diseases. References [1] EULAR/PRINTO/PRES, Citeria for Henoch– Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008, Part II: Final classification criteria, AnnRheum Dis 69 (2010) 798–806.[2] Seza Ozen, Stephen D. Marks, Paul Brogan et al, European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative, Rheumatology, 58(9) (2019) 1607–1616.[3] L.J. Liu,J. Yu and Y.N. Li, Clinical characteristics of Henoch-Schonlein purpura in children, Zhongguo dang dai er ke za zhi. Chinese journal of contemporary pediatrics 17(10) (2015) 1079-1083.[4] Le Thi Minh Huong, Thuc Thanh Huyen, study about characteristics of clinical and paraclinical manifestations of HSP in children in National Pedicatrics of hospital, Journal of Practical Medicine 874(6) (2013) 91-94 (in Vietnamese).[5] Y.H. Lee, Y.B. Kim, J.W. Koo et al, Henoch-Schonlein Purpura in children hospitalized at a tertiary hospital during 2004-2015 in Korea: epidemiology and clinical management,Pediatric gastroenterology, hepatology & nutrition 19(3) (2016) 175-185.[6] I.M. Buscatti, B.B. Casella, N.E. Aikawa et al, Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center. Clin Rheumatol 37(5) (2018) 1319-1324.[7] J.D. Delbet, J. Hogan, B. Aoun et al, Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents. Pediatr Nephrol 32(7) (2017) 1193-1199.        

scholarly journals HENOCH-SCHÖNLEIN PURPURA NEPHRITIS IN CHILDREN: EXPERI-ENCE OF THE TWO TERTIARY CARE CENTERS FOR PEDIATRIC AND ADOLESCENT RHEUMATOLOGY OF THE REPUBLIC OF CROATIA FROM 2006 TO 2017

2018 ◽  
Vol 141 (5-6) ◽  
pp. 115-126
Keyword(s):  
Kidney Disease ◽  
Tertiary Care ◽  
University Hospital ◽  
Henoch Schonlein Purpura ◽  
Renal Complications ◽  
Number Of Patients ◽  
Isolated Proteinuria ◽  
Schonlein Purpura ◽  
Henoch Schönlein Purpura ◽  
Purpura Nephritis

Aim: To determine types of renal complications, indications for biopsy, treatment methods and possible outcomes in patients with Henoch-Schönlein purpura nephritis. Patients and methods: Retrospective analysis of medical data of HSP patients treated at the Department of Paediatrics, University Hospital Centre Zagreb, and the Department of Paediatrics, University Hospital Centre Split, during the period from 2006 to 2017, who developed kidney disease according to EULAR/PRINTO/PRES criteria. Results: Out of 378 patients diagnosed with HSP, 81 (21.4%) developed kidney disease, out of whom 43 boys (53.1%) and 38 girls (46.9%), with the median age 8.4 years (2.5–16.8).. A statistically significant increase of patients with HSP was during autumn and winter. There is a greater chance of nephritis with the increase of patients age at diagnosis. For every year (from 1 to 17 years) the chances increase by around 2.25%. Equal number of patients, 44.45%, had both hematuria and proteinuria or isolated hematuria, and only 11.1% isolated proteinuria. Renal biopsy was performed in 37 patients (45.7%), and most biopted patients were from concurrent hematuria and proteinuria group (70.3%). Children with isolated hematuria or with isolated proteinuria were most often treated with corticosteroids while children with hematuria and proteinuria were most often treated with corticosteroids and angiotensin-converting enzyme inhibitors. Immunosuppressives were used in 16% of the patients, including most of those in the group with concurrent hematuria and proteinuria (69.2%). Only one patient (1.2%) developed renal insufficiency with the need for dialysis, while the outcome of the others was evaluated as good. Conclusion: Renal complications are the most important factor in the outcome of patients with HSP. For the optimal treatment of these patients it is necessary to bring consensus about the indications for kidney biopsy in HSP, and also to validate the existing pathohistological classification to affirm which one best correlates with the adverse outcome of the disease.

Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children

2014 ◽  
Vol 11 (4) ◽  
pp. 338-345 ◽  
Author(s):  
Yan-Jie Huang ◽  
Xiao-Qing Yang ◽  
Wen-Sheng Zhai ◽  
Xian-Qing Ren ◽  
Qing-Yin Guo ◽  
...  
Keyword(s):  
Clinicopathological Features ◽  
Henoch Schonlein Purpura ◽  
Schonlein Purpura ◽  
Henoch Schönlein Purpura ◽  
Purpura Nephritis

scholarly journals Biopsy-proven Henoch-Schönlein purpura nephritis: a single center experience

2020 ◽  
Author(s):  
Eda Didem Kurt-Şükür ◽  
Thivya Sekar ◽  
Kjell Tullus
Keyword(s):  
Angiotensin Receptor Blockers ◽  
Laboratory Data ◽  
Treatment Modalities ◽  
Oxford Classification ◽  
Henoch Schonlein Purpura ◽  
Nephritic Syndrome ◽  
Kidney Involvement ◽  
Schonlein Purpura ◽  
Henoch Schönlein Purpura ◽  
Purpura Nephritis

Abstract Background Knowledge on normal progress and treatment of Henoch-Schönlein purpura nephritis (HSPN) is limited. This study reviews outcome, clinical, pathological, and therapeutic factors affecting the prognosis of HSPN patients. Methods Forty-nine children with biopsy-confirmed HSPN diagnosed between September 2008 and 2018 were included. Demographics, clinical and laboratory data, treatment, and outcome were recorded at the time of biopsy, 3, 6, 12, and 24 months and at last visit. Clinical outcome was graded according to Meadow’s criteria. Results The median age at time of biopsy was 10.1 years (IQR:5.7) and female/male ratio 24/25. At presentation, 40.8% of patients had nonnephrotic proteinuria, 18.4% nephrotic syndrome (NS), 4.1% nephritic syndrome (NephrS), and 36.7% NephrS+NS. There were 11 patients with an estimated glomerular filtration rate below 90 ml/min/1.73 m2. Biopsy specimens were classified according to International Study of Kidney Diseases in Children (ISKDC) and Oxford Classification MEST-C scoring systems. Forty-one patients received angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, 37 patients steroids, and 35 patients other immunosuppressive medications. At last visit, 24 patients had stage 1 chronic kidney disease (CKD), three stage 2 CKD, and two had stage 5 CKD. Neither clinical parameters nor ISKDC biopsy grade or treatment modalities effected the final outcome. The Oxford classification showed significantly increased segmental glomerulosclerosis in patients with unfavorable outcome. Favorable outcome was associated with shorter time from kidney involvement to biopsy and start of treatment. Conclusion A large proportion of patients continued to show signs of CKD at last follow-up while only a small proportion developed stage 5 CKD.

Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis

2018 ◽  
Vol 34 (4) ◽  
pp. 663-670 ◽  
Author(s):  
Xiao-qing Yang ◽  
Yan-jie Huang ◽  
Wen-sheng Zhai ◽  
Xian-qing Ren ◽  
Qing-yin Guo ◽  
...  
Keyword(s):  
Henoch Schonlein Purpura ◽  
Schonlein Purpura ◽  
Nephrotic Range Proteinuria ◽  
Henoch Schönlein Purpura ◽  
Purpura Nephritis

The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan

2010 ◽  
Vol 42 (4) ◽  
pp. 1023-1029 ◽  
Author(s):  
Yukihiko Kawasaki ◽  
Kazuhide Suyama ◽  
Eichi Yugeta ◽  
Masahiko Katayose ◽  
Shigeo Suzuki ◽  
...  
Keyword(s):  
Henoch Schonlein Purpura ◽  
Fukushima Prefecture ◽  
Schonlein Purpura ◽  
Henoch Schönlein Purpura ◽  
Purpura Nephritis
Sign in / Sign up

Export Citation Format

Share Document